Abstract:Background: Genetic overexpression or pharmacological activation of heme oxygenase (HO) are identified as potential therapeutic target for spinal cord injury (SCI); however, the role of carbon monoxide (CO), which is a major product of haem degenerated by HO, in SCI remains unknown. Applying hemin or chemicals which may regulate HO expression or activity to increase CO production are inadequate to elaborate the direct role of CO. Here, we respond to this question and explain its possible protective mechanism. Methods: Rat SCI model was performed with a vascular clip (30g) compressing at T9 vertebral level for 1min and CO was delivered immediately after SCI by CO releasing molecule 3 (CORM-3), the classical donor of CO. The neurological deficits and neuron survival were assessed. Inflammasome activation and inositol-requiring enzyme 1 (IRE1) pathway were measured by various molecular biological methods. For in vitro study, oxygen glucose deprivation (OGD) simulated the SCI-inflammasome activation in cultured the primary neurons. Findings: CORM-3 restrained inflammasome activation and pyroptosis occurrence, which consequently relieved neuron death and improved motor functional recovery following SCI. As a pivotal sensor involving in endoplasmic reticulum stress-medicated inflammasome activation, IRE1 and its downstream X-box binding protein 1 (XBP1) were activated in SCI tissues as well as in OGD neurons; while inhibition of IRE1 by STF-083010 in SCI rats or by si-RNA in OGD neurons suppressed inflammasome activation and pyroptosis. Interestingly, the SCI/OGD-stimulated IRE1 activation was attenuated by CORM-3 treatment. Interpretations: CO may alleviate neuron death and improve motor functional recovery in SCI through IRE1 regulation, and administration of CO could be a promising therapeutic strategy for SCI. Funding Statement: This study is supported by National Natural Science Foundation of China (81601963, 81873992, 81572227); Wenzhou Science and Technology Bureau Foundation (Y20170083, Y20170092). Declaration of Interests: The authors declare no competing financial interest. Ethics Approval Statement: The protocol for animal care and use conformed to the Guide for the Care and Use of Laboratory Animals from the National Institutes of Health and was approved by the Animal Care and Use Committee of Wenzhou Medical University

Carbon monoxide-releasing molecule-3 exerts neuroprotection effects after cardiac arrest in mice: A randomized controlled study

Exogenous Administration of Carbon Monoxide Alleviates Neuron Death after Spinal Cord Injury via Inflammasome Regulation

Structural and Functional Improvement of Injured Brain after Severe Acute Carbon Monoxide Poisoning by Stem Cell–based Therapy in Rats*

Carbon monoxide-releasing molecule-2 ameliorates postresuscitation myocardial dysfunction in rat via mitochondrial-mediated apoptosis pathway and the regulation of mitochondrial dynamics

Effects of Carbon Monoxide Releasing Molecule-2 on Post-Resuscitation Myocardial Dysfunction

Carbon monoxide-releasing molecule-3 ameliorates traumatic brain injury-induced cardiac dysfunctions via inhibition of pyroptosis and apoptosis

Exogenous Carbon Monoxide Protects Against Mitochondrial DNA‑induced Hippocampal Pyroptosis in a Model of Hemorrhagic Shock and Resuscitation.

Novel Role of Carbon Monoxide in Improving Neurological Outcome after Cardiac Arrest in Aged Rats: Involvement of Inducing Mitochondrial Autophagy.

Carbon monoxide-releasing molecules attenuate postresuscitation myocardial injury and protect cardiac mitochondrial function by reducing the production of mitochondrial reactive oxygen species in a rat model of cardiac arrest.

Carbon Monoxide Improves Neurologic Outcomes by Mitochondrial Biogenesis after Global Cerebral Ischemia Induced by Cardiac Arrest in Rats

Spontaneous Hypothermia Ameliorated Inflammation and Neurologic Deficit in Rat Cardiac Arrest Models Following Resuscitation

Remote Ischemic Postconditioning Alone and Combined with Therapeutic Hypothermia Improve Neurological Outcomes after Cardiopulmonary Resuscitation in A Porcine Model

THE PROTECTIVE EFFECT OF C23 IN A RAT MODEL OF CARDIAC ARREST AND RESUSCITATION

Methane-Rich Saline Alleviates CA/CPR Brain Injury by Inhibiting Oxidative Stress, Microglial Activation-Induced Inflammatory Responses, and ER Stress-Mediated Apoptosis

The protective effect of a short peptide derived from cold-inducible RNA-binding protein in a rat model of cardiac arrest and resuscitation

Effects of NLRP3 Inflammasome Blockade on Postresuscitation Cerebral Function in a Rat Model of Cardiopulmonary Resuscitation

Effects of the Selective NLRP3-Inflammasome Inhibitor MCC950 on Post-Resuscitationyocardial and Cerebral Function in a Rat Model of Cardiopulmonary Resuscitation

Carbon monoxide as a cellular protective agent in a swine model of cardiac arrest protocol

Improvement in Outcomes and Prevention of Multiple Organ Dysfunction Syndrome After Cardiac Arrest and Successful Cardiopulmonary Resuscitation by Systemic Administration of Bumetanide in Male Mice

Minocycline Attenuates Microglial Response and Reduces Neuronal Death after Cardiac Arrest and Cardiopulmonary Resuscitation in Mice

MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation